Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer

The expression of estrogen receptor α (ER) in breast cancers may be indicative of a favorable prognosis and most of these cancers respond to anti-estrogens or aromatase inhibitors. However, ER-positive (ER(+)) breast cancers receiving anti-hormone and/or chemotherapy sometimes lose their ER expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Dong-Xu, Wu, Xiao-Li, Lu, Chun-Xiao, Gu, Xiao-Ting, Zhang, Guang-Yuan, Ma, Xin, Liu, De-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783585/
https://www.ncbi.nlm.nih.gov/pubmed/29039577
http://dx.doi.org/10.3892/or.2017.6033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783585/
https://www.ncbi.nlm.nih.gov/pubmed/29039577
http://dx.doi.org/10.3892/or.2017.6033

Ejemplares similares